Skip to Content

DSM Firmenich AG DSFIR

Morningstar Rating
€103.75 −1.95 (1.84%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

DSM-Firmenich Earnings: In-Line EBITDA Delivery; Volume Growth for Fragrances Disappoints

We confirm our EUR 130 fair value estimate for wide-moat DSM-Firmenich after it reported first-quarter 2024 adjusted EBITDA of EUR 463 million, in line with the Vara consensus. This represents an 11% decrease compared with the same period last year, which was mainly attributed to ongoing challenging market conditions in vitamins. Still, management indicated that market momentum is improving and confirmed full-year EBITDA guidance of at least EUR 1.9 billion, which is broadly aligned with our forecast of full-year adjusted EBITDA of around EUR 2 billion.

Price vs Fair Value

DSFIR is trading at a 19% discount.
Price
€105.70
Fair Value
€418.00
Uncertainty
Medium
1-Star Price
€252.40
5-Star Price
€44.00
Economic Moat
Gjyg
Capital Allocation
Tftcltdh

Bulls Say, Bears Say

Bulls

The combination of DSM and Firmenich provides a compelling proposition for large multinational customers, with the company able to provide a wide range of specialized ingredients and solutions across nutrition as well as flavor and fragrance.

Bears

The limited overlap between DSM's and Firmenich's businesses will make it difficult for management to achieve all the planned revenue synergies.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DSFIR is a good fit for your portfolio.

News

Trading Information

Previous Close Price
€105.70
Day Range
€99.94107.85
52-Week Range
€75.45120.66
Bid/Ask
€103.10 / €104.50
Market Cap
€27.52 Bil
Volume/Avg
993,886 / 481,095

Key Statistics

Price/Earnings (Normalized)
64.92
Price/Sales
2.32
Dividend Yield (Trailing)
1.51%
Dividend Yield (Forward)
2.37%
Total Yield
1.51%

Company Profile

DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from animal feed to medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
Sector
Consumer Defensive
Industry
Household & Personal Products
Stock Style Box
Large Growth
Total Number of Employees
30,000

Competitors

Valuation

Metric
DSFIR
IFF
SY1
Price/Earnings (Normalized)
64.9236.0539.50
Price/Book Value
1.221.473.88
Price/Sales
2.321.872.98
Price/Cash Flow
23.6322.4521.17
Price/Earnings
DSFIR
IFF
SY1

Financial Strength

Metric
DSFIR
IFF
SY1
Quick Ratio
1.200.741.54
Current Ratio
1.961.672.89
Interest Coverage
−3.42−5.635.75
Quick Ratio
DSFIR
IFF
SY1

Profitability

Metric
DSFIR
IFF
SY1
Return on Assets (Normalized)
1.31%0.70%4.34%
Return on Equity (Normalized)
2.01%1.40%9.53%
Return on Invested Capital (Normalized)
1.93%1.90%6.39%
Return on Assets
DSFIR
IFF
SY1
See how this stock stacks up to its competitors with Morningstar Investor

Household & Personal Products Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
PG
Procter & Gamble CoCkpvdqtxCnx$385.6 Bil
UL
Unilever PLC ADRYztddnhnDlzn$129.5 Bil
CL
Colgate-Palmolive CoFznypptpdpRvlg$75.4 Bil
KMB
Kimberly-Clark CorpDsznthcwkmFbgxmk$46.0 Bil
EL
The Estee Lauder Companies Inc Class AZfxhscmjkVlckp$45.7 Bil
RBGLY
Reckitt Benckiser Group PLC ADRRcmydpktZtspr$39.4 Bil
KVUE
Kenvue IncKgnxtvhbVvwj$36.1 Bil
CHD
Church & Dwight Co IncSzwrwznlpXwmww$25.9 Bil
CLX
Clorox CoLwrzxbkjrKtzv$17.3 Bil
COTY
Coty Inc Class AWkljfLvn$10.1 Bil

Sponsor Center